Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

In these unlocked downloadable slides, experts provide a review of therapeutic interventions for NAFLD/NASH including key recommendations from the latest clinical care guidelines and the safety and efficacy of emerging agents.

Rohit Loomba, MD, MHSc
Brent Tetri, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 7.6 MB
Released: November 4, 2022


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Novo Nordisk Inc.

Related Content

Learn from an expert about the use of setmelanotide for hunger and weight management in pediatric patients with Bardet-Biedl syndrome, from Clinical Care Options (CCO)

Stephanie Sisley, MD Released: January 9, 2023

Hear from an expert on how to incorporate incretin-based therapies to address obesity and cardiovascular disease in your practice, from Clinical Care Options (CCO)

person default Lisa Coco, MSN, CRNP, CDCES Released: January 9, 2023

Review an expert’s summary of guideline-recommended management of NAFLD and how we can better care for these patients, from Clinical Care Options (CCO)

Rohit Loomba, MD, MHSc Released: January 4, 2023

A quick reference guide to identify obesity specialists in New York, from Clinical Care Options (CCO).

Released: December 13, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings